Many Americans with Hashimoto’s thyroiditis are now also using GLP‑1 medications to aid weight loss. Because levothyroxine dosing is based on body weight, losing a notable amount of weight can change how the hormone works in the body.
How weight loss affects thyroid medication
Research from Epic examined 21,538 patients with hypothyroidism who were prescribed a GLP‑1 drug. Those who lost more than five pounds showed a measurable drop in TSH, the blood test doctors use to gauge thyroid dosing. Patients who gained weight did not see a significant change.
If the lower TSH is ignored, patients may receive too much levothyroxine, risking hyperthyroidism. Symptoms can include palpitations, anxiety, heat intolerance, fatigue, muscle weakness and shaking.
Age‑related risks
A 2025 review in Thyroid notes that older patients face higher health risks. Bone loss becomes a concern around age 50, and cardiac risk rises sharply after age 60, potentially leading to atrial fibrillation, strokes or heart failure.
Guidance for patients
Medical societies recommend rechecking TSH when weight drops more than 4.5 kilograms (just under 10 pounds) or if thyroid‑related symptoms appear. After stabilization, testing is typically done every six to twelve months. The American Thyroid Association also advises dose reassessment after large weight changes.
Although no direct drug interaction between GLP‑1 agents and thyroid medication has been proven, weight loss and altered gastric emptying likely drive the observed changes.
Practical steps
- Obtain a full thyroid panel (TSH, free T4, free T3) before starting a GLP‑1 drug.
- Ask your thyroid specialist how often TSH should be checked during weight loss; many suggest testing after a loss of more than 4.5 kg.
- Communicate weight‑loss progress openly with both your weight‑loss and thyroid providers.
- Take levothyroxine on an empty stomach at the same time each day, separate from other meds.
- Report any new symptoms such as anxiety, heat intolerance, tremors or palpitations to your clinician.
- Preserve muscle mass with resistance training two to three times weekly and adequate protein intake.
Ongoing research is exploring whether GLP‑1 drugs might affect thyroid autoimmunity itself, but current evidence is limited. Patients should discuss any concerns with their healthcare team to ensure safe and effective treatment.
Original reporting: KRDO (Colorado Springs metro) — read the source article.
